Package 31722-505-10

{"route": ["ORAL"], "spl_id": "e5515515-0ee0-e288-e053-2995a90a3d7c", "openfda": {"nui": ["N0000175463", "N0000175460", "N0000009948", "N0000190118", "N0000187064"], "unii": ["99DK7FVK1H"], "rxcui": ["199422"], "spl_set_id": ["61409678-d2f6-42cd-b03d-b26b11b39641"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (31722-505-01)", "package_ndc": "31722-505-01", "marketing_start_date": "20120523"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (31722-505-05)", "package_ndc": "31722-505-05", "marketing_start_date": "20120523"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (31722-505-10)", "package_ndc": "31722-505-10", "marketing_start_date": "20120523"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (31722-505-60)", "package_ndc": "31722-505-60", "marketing_start_date": "20120523"}], "brand_name": "Nevirapine", "product_id": "31722-505_e5515515-0ee0-e288-e053-2995a90a3d7c", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "31722-505", "generic_name": "Nevirapine", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nevirapine", "active_ingredients": [{"name": "NEVIRAPINE", "strength": "200 mg/1"}], "application_number": "ANDA078584", "marketing_category": "ANDA", "marketing_start_date": "20120523", "listing_expiration_date": "20261231"}